Erika B Rangel

Summary

Country: Brazil

Publications

  1. ncbi request reprint Charcot neuroarthropathy after simultaneous pancreas-kidney transplant
    Erika B Rangel
    Division of Nephrology, Federal University of Sao Paulo, Brazil
    Transplantation 94:642-5. 2012
  2. doi request reprint The metabolic and toxicological considerations for immunosuppressive drugs used during pancreas transplantation
    Erika B Rangel
    Federal University of Sao Paulo, SP, Brazil
    Expert Opin Drug Metab Toxicol 8:1531-48. 2012
  3. pmc The evolution of diabetic chronic complications after pancreas transplantation
    Joao R de Sa
    Department of Medicine, Division of Endocrinology of Federal University of So Paulo, So Paulo, Brazil
    Diabetol Metab Syndr 1:11. 2009
  4. ncbi request reprint Risk factors for the development of posttransplantation diabetes mellitus in simultaneous pancreas and kidney recipients
    E B Rangel
    Nephrology Division, Federal University of Sao Paulo, Sao Paulo, SP, Brazil
    Transplant Proc 36:982-3. 2004
  5. doi request reprint Hemoglobin and hematocrit at the end of hemodialysis: a better way to adjust erythropoietin dose?
    Erika B Rangel
    Division of Nephrology, Universidade Federal de Sao Paulo, Sao Paulo, Brazil
    J Artif Organs 13:63-6. 2010
  6. ncbi request reprint Family history of diabetes as a new determinant of insulin sensitivity and secretion in patients who have undergone a simultaneous pancreas-kidney transplant
    Erika B Rangel
    Division of Nephrology, Universidade Federal de Sao Paulo, Sao Paulo, Brazil
    Exp Clin Transplant 8:29-37. 2010
  7. doi request reprint Labile plasma iron generation after intravenous iron is time-dependent and transitory in patients undergoing chronic hemodialysis
    Erika B Rangel
    Dialysis Center, Hospital Israelita Albert Einstein, University of Sao Paulo, Sao Paulo, Brazil
    Ther Apher Dial 14:186-92. 2010
  8. ncbi request reprint Belatacept in clinical and experimental transplantation - progress and promise
    Erika B Rangel
    Nephrology Division, Federal University of Sao Paulo and Albert Einstein Hospital, Sao Paulo, Brazil
    Drugs Today (Barc) 46:235-42. 2010
  9. doi request reprint Delayed kidney allograft function after simultaneous pancreas-kidney transplantation
    E B Rangel
    Division of Nephrology, Universidade Federal de Sao Paulo, Sao Paulo, Brazil
    Transplant Proc 42:3655-9. 2010
  10. doi request reprint Antibody-mediated rejection (AMR) after pancreas and pancreas-kidney transplantation
    Erika B Rangel
    Pancreas Kidney Transplantation Unit, Hospital Israelita Albert Einstein HIAE, Sao Paulo, Brazil
    Transpl Int 23:602-10. 2010

Collaborators

Detail Information

Publications20

  1. ncbi request reprint Charcot neuroarthropathy after simultaneous pancreas-kidney transplant
    Erika B Rangel
    Division of Nephrology, Federal University of Sao Paulo, Brazil
    Transplantation 94:642-5. 2012
    ..Immunosuppressive regimen is associated with several metabolic adverse effects. Bone loss and fractures are frequent after transplantation and involve multifactorial mechanisms...
  2. doi request reprint The metabolic and toxicological considerations for immunosuppressive drugs used during pancreas transplantation
    Erika B Rangel
    Federal University of Sao Paulo, SP, Brazil
    Expert Opin Drug Metab Toxicol 8:1531-48. 2012
    ..Reduction in technical failure loss and early acute rejection rates contributed to prolong pancreas graft survival. However, drug toxicity affects negatively both short- and long-term follow-ups...
  3. pmc The evolution of diabetic chronic complications after pancreas transplantation
    Joao R de Sa
    Department of Medicine, Division of Endocrinology of Federal University of So Paulo, So Paulo, Brazil
    Diabetol Metab Syndr 1:11. 2009
    ..Recent studies have demonstrated clashing outcomes regarding isolated pancreas transplantations, a fact which reinforces the need for a more discerning selection of patients for this procedure...
  4. ncbi request reprint Risk factors for the development of posttransplantation diabetes mellitus in simultaneous pancreas and kidney recipients
    E B Rangel
    Nephrology Division, Federal University of Sao Paulo, Sao Paulo, SP, Brazil
    Transplant Proc 36:982-3. 2004
    ..25 +/- 3.13 kg/m(2) vs 24.67 +/- 2.38 kg/m(2); P =.034). Two-hour CG may be a useful tool to screen the diabetogenic effects of corticosteroids. A BMI increase should be discouraged due to the risk of PTDM...
  5. doi request reprint Hemoglobin and hematocrit at the end of hemodialysis: a better way to adjust erythropoietin dose?
    Erika B Rangel
    Division of Nephrology, Universidade Federal de Sao Paulo, Sao Paulo, Brazil
    J Artif Organs 13:63-6. 2010
    ..Inadvertent high levels of hemoglobin could be one explanation why patients present higher rates of cardiovascular and access-related events, especially when monitored online by use of the BVM to achieve the dry weight...
  6. ncbi request reprint Family history of diabetes as a new determinant of insulin sensitivity and secretion in patients who have undergone a simultaneous pancreas-kidney transplant
    Erika B Rangel
    Division of Nephrology, Universidade Federal de Sao Paulo, Sao Paulo, Brazil
    Exp Clin Transplant 8:29-37. 2010
    ..In that model, fasting plasma glucose and C-peptide levels are used to evaluate insulin sensitivity and beta-cell function...
  7. doi request reprint Labile plasma iron generation after intravenous iron is time-dependent and transitory in patients undergoing chronic hemodialysis
    Erika B Rangel
    Dialysis Center, Hospital Israelita Albert Einstein, University of Sao Paulo, Sao Paulo, Brazil
    Ther Apher Dial 14:186-92. 2010
    ..0003, respectively). LPI generation after intravenous saccharate administration is time-dependent and transitorily detected during hemodialysis. The LPI increment had a positive correlation to iron and transferrin saturation...
  8. ncbi request reprint Belatacept in clinical and experimental transplantation - progress and promise
    Erika B Rangel
    Nephrology Division, Federal University of Sao Paulo and Albert Einstein Hospital, Sao Paulo, Brazil
    Drugs Today (Barc) 46:235-42. 2010
    ..Studies on nonhuman primates, as well as phase II and III clinical trials are here reviewed. Belatacept is a promising therapy in organ transplantation and in the future can be used to induce tolerance...
  9. doi request reprint Delayed kidney allograft function after simultaneous pancreas-kidney transplantation
    E B Rangel
    Division of Nephrology, Universidade Federal de Sao Paulo, Sao Paulo, Brazil
    Transplant Proc 42:3655-9. 2010
    ..Simultaneous pancreas-kidney transplantation (SPKT) is one of the treatments for insulin-dependent chronic renal failure patients...
  10. doi request reprint Antibody-mediated rejection (AMR) after pancreas and pancreas-kidney transplantation
    Erika B Rangel
    Pancreas Kidney Transplantation Unit, Hospital Israelita Albert Einstein HIAE, Sao Paulo, Brazil
    Transpl Int 23:602-10. 2010
    ..015). These data suggest that C4d staining should be routinely investigated when pancreas allograft dysfunction is present because of its high detection rate in cases of rejection...
  11. doi request reprint Mycophenolate mofetil versus enteric-coated mycophenolate sodium after simultaneous pancreas-kidney transplantation
    E B Rangel
    Nephrology Division, Universidade Federal de Sao Paulo, Rua Botucatu, 740 VilaClementino, 04023 900 São Paulo, Brazil
    Transplant Proc 41:4265-9. 2009
    ....
  12. pmc Kidney transplant in diabetic patients: modalities, indications and results
    Erika B Rangel
    Division of Nephrology, Universidade Federal de Sao Paulo, Brazil
    Diabetol Metab Syndr 1:2. 2009
    ....
  13. ncbi request reprint Impact of pancreatic allograft function on 1-year survival rates after simultaneous pancreatic-renal transplant
    Erika B Rangel
    Universidade Federal de Sao Paulo, Brazil
    Exp Clin Transplant 6:301-6. 2008
    ..We sought to identify the main influences on pancreatic and patient survival rates after simultaneous pancreas-kidney transplants...
  14. ncbi request reprint Thrombotic microangiopathy after simultaneous pancreas-kidney transplantation
    Erika B Rangel
    Nephrology Division, Universidade Federal de Sao Paulo, Brazil
    Clin Transplant 21:241-5. 2007
    ..7 mL/min/1.73 m(2) and 57.9 mL/min/1.73 m(2) in patients with systemic and localized TMA, respectively. In conclusion, sirolimus is an alternative to TMA associated with tacrolimus...
  15. ncbi request reprint Up-regulation of cyclooxygenase-2 in different grades of acute human renal allograft rejection
    Erika B Rangel
    Division of Nephrology, Hospital do Rim e Hipertensão and Universidade Federal de São Paulo, Brazil
    Prostaglandins Leukot Essent Fatty Acids 76:235-43. 2007
    ..Cyclooxygenase-2 (COX-2) is up-regulated by a variety of stimuli that are associated with tissue injury and inflammation...
  16. ncbi request reprint Severe hyperkalemic type 4 renal tubular acidosis after kidney transplantation: a case report
    E B Rangel
    Universidade Federal de Sao Paulo, Sao Paulo, SP, Brazil
    Transplant Proc 38:3112-5. 2006
    ..Hyperkalemia after transplantation is a common event, occurring in up to 70% of patients. It is usually asymptomatic but sometimes manifests as muscle weakness or cardiac arrhythmias...
  17. doi request reprint Pancreas transplantation alone in children: a case report
    Marcelo Perosa
    Pancreas Transplant Service, Albert Einstein Hospital, Sao Paulo, Brazil
    Clin Transplant 23:964-7. 2009
    ..His quality-of-life is judged to be superior to his insulin dependent state prior to transplantation. According to the medical literature, this is the youngest patient ever to undergo PTA...
  18. ncbi request reprint Up-regulation of cyclooxygenase-2 during acute human renal allograft rejection
    Erika B Rangel
    Division of Nephrology, Hopsital do Rim e Hipertensão and Universidade Federal de São Paulo, Brazil
    Clin Transplant 19:543-50. 2005
    ..However, there is poor information about them during renal allograft rejection. The purpose of this study was to analyze cyclooxygenases expression in renal tissue allograft during acute rejection...
  19. ncbi request reprint Tim-3 expression in human kidney allografts
    Viviane C Ponciano
    Laboratory of Clinical and Experimental Immunology, Nephrology Division, Universidade Federal de Sao Paulo, Rua Botucatu 740, Vila Clementino, 04023 900, Sao Paulo, SP, Brazil
    Transpl Immunol 17:215-22. 2007
    ..Here, we studied Tim-3 mRNA expression together with molecular markers of T-cell activation and cytotoxicity, in rejected human kidney grafts...
  20. pmc C-kit(+) cells isolated from developing kidneys are a novel population of stem cells with regenerative potential
    Erika B Rangel
    Interdisciplinary Stem Cell Institute, Sao Paulo, Sao Paulo, Brazil Sociedade Beneficente Albert Einstein, Albert Einstein Hospital, Sao Paulo, Sao Paulo, Brazil Division of Nephrology, Department of Medicine, Federal University of Sao Paulo, Sao Paulo, Sao Paulo, Brazil
    Stem Cells 31:1644-56. 2013
    ..These cells have important biological and therapeutic implications...